AIM
FMS icon

Acrospire Investment Management’s Fresenius Medical Care FMS Stock Holding History

Acrospire Investment Management’s Portfolio FMS Stock Details FMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,107
Closed -$54K – 537
2017
Q2 		$54K Sell
1,107
-200
-15% -$9.21K 0.05% 778
2017
Q1 		$55K Buy
1,307
+1,265
+3,012% +$52.3K 0.05% 853
2016
Q4 		$2K Sell
42
-100
-70% -$4.08K ﹤0.01% 2124
2016
Q3 		$6K Buy
+142
New +$6.36K ﹤0.01% 1792

Other funds holding FMS

HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAMU
Marathon Asset Management (UK) London, United Kingdom $2.61B AUM 27.14% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Acrospire Investment Management's FMS Position: Q3 2017 in Review

Acrospire Investment Management sold out of Fresenius Medical Care (FMS) in Q3 2017, closing a stake of 1,107 shares — an estimated $54K sold.

Acrospire Investment Management first reported a position in FMS in Q3 2016 and held it in 4 quarters. The position peaked at $55K in Q1 2017. 205 funds tracked by Wall St. Rank hold FMS as of Q3 2017.

  • Acrospire Investment Management reported no remaining Fresenius Medical Care position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,107 Fresenius Medical Care shares in Q3 2017, an estimated $54K.
  • Acrospire Investment Management first reported a position in Fresenius Medical Care in Q3 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Fresenius Medical Care position peaked at $55K in Q1 2017.
  • 205 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.